New Delhi: Drug firm Vivimed Labs has recently received an establishment inspection report (EIR) from the US health regulator for its Mexico manufacturing facility after an inspection.
“The company’s API manufacturing facility located in CUERNAVACA, Mexico was recently inspected by the United States Food and Drug Administration (USFDA) in compliance with their requirements,” Vivimed Labs said in a BSE filing.
“The inspection was successful and company obtained EIR. This was a routine inspection by the USFDA,” it added.
Vivimed Labs Limited is an India-based global supplier of speciality chemicals and pharmaceuticals. Vivimed is a manufacturer of active pharmaceutical ingredients, active ingredients for home and personal care, hair dyes, imaging chemicals and photochromics.
Read Also: Vivimed Labs to acquire Hungary-based Soneas
